Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by 1mapleleafon Aug 10, 2017 7:45am
262 Views
Post# 26564779

lets stop the bull sh...t

lets stop the bull sh...tIs this it for pli ,  does the fda  say no, does the china deal fall through,  is all this just smoke and mirrors ,  do the drugs which we all think are soo wonderful  get non- approval , i would think having  such great potential products someone is willing to pay a few bucks for this company, and keep it from going lower  and lower  and lower ,  is mgmt. the problem  not enough  PR  WORK.  Its time to shi.......t   or get off the pot  i think.  I am still waiting.  does someone know something we dont.  hoping for the best,  glta. 
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse